Pelago Bioscience AB logo — Pelago Bioscience

Pelago Bioscience AB

Pelago Bioscience

Founded 2013 Sweden Sweden 60 employees Venture round Biotechnology, Pharmaceutical

General Information

Company Name Pelago Bioscience AB
Founded Year 2013
Location Sweden Sweden
Employees 60
Industries Biotechnology, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Pelago Bioscience AB. To contact Pelago Bioscience AB, visit pelagobio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Pelago Bioscience AB

Pelago Bioscience AB is a biotechnology and pharmaceutical startup, headquartered in Sweden and founded in 2013. The company has recently received a Venture Round investment on 16 August 2023 from Impilo. Pelago Bioscience specializes in providing innovative solutions in drug discovery through its proprietary CETSA® (Cellular Thermal Shift Assay) technology. This technology offers a more reliable and actionable understanding of drug-target interactions, ultimately minimizing late-stage risks and accelerating the decision-making process for drug development. Through their services, Pelago Bioscience aims to deliver fast and early confidence, valuable insights, and extended support to their clients, thereby significantly reducing project costs and timelines. With its strong focus on biological relevance and commitment to being a trusted partner, Pelago Bioscience is poised to make meaningful contributions in the field of drug discovery.

Taxonomy: drug discovery, target engagement, CETSA® technology, diagnostics, clinical trials, medicine development, diagnostic kits, companion diagnostics, treatment monitoring, physiologically relevant data, in vitro, in vivo, patient treatment

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Impilo
16 Aug 2023

Pelago Bioscience AB Alternatives & Competitors

Pelago Bioscience AB vs

Clarity is developing next-generation products to address the growing need for radiopharmaceuticals...

Venture round
61 employees
Biotechnology, Health Care
Pelago Bioscience AB vs

Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies

Post-IPO Secondary
28 employees
AI, Biopharma
Pelago Bioscience AB vs

By doing research we help bring new advanced drugs to market that enhance the quality of patient’s...

11 employees
Biotechnology, Health Care

FAQ About Pelago Bioscience AB

Pelago Bioscience
Pelago Bioscience AB was founded in 2013.
Pelago Bioscience AB is headquartered in Sweden.
Pelago Bioscience AB operates in Biotechnology and Pharmaceutical. Its work centres on drug discovery, target engagement, CETSA® technology and diagnostics.
Pelago Bioscience AB has approximately 60 employees.
Pelago Bioscience AB has completed 1 funding round. The latest funding stage is Venture round.
Top alternatives and competitors to Pelago Bioscience AB include Clarity Pharmaceuticals, Lantern Pharma Inc. (Nasdaq: LTRN), Elite Clinical Studies, LLC, Inspirna, Inc., Generex Biotechnology Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pelago Bioscience AB and Clarity Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pelago Bioscience AB, https://bouncewatch.com/company/pelago-bioscience-ab, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes